Arcturus Therapeutics Holdings Inc. / Estimates

    Fiscal Year Revenue Net income Net margin Free cash flow FCF margin
    (estimated) €629.86M +54.9% €278.91M +97.9% 44.3% +0.096 pp N/A N/A
    (estimated) €406.62M +136.4% €140.96M +912.6% 34.7% +0.27 pp N/A N/A
    (estimated) €172.00M +98.7% €13.92M -123.7% 8.1% +0.76 pp N/A N/A
    (estimated) €86.54M +13.2% -€58.63M -1.0% -67.8% +0.097 pp N/A N/A
    (estimated) €76.45M -35.2% -€59.19M -14.3% -77.4% -0.19 pp N/A N/A
    €118.04M -12.3% -€69.04M +172.3% -58.5% -0.40 pp -€50.41M +288.9% -42.7% -0.33 pp
    €134.55M -23.3% -€25.35M -417.9% -18.8% -0.23 pp -€12.96M -138.3% -9.6% -0.29 pp
    €175.50M +1,564.8% €7.97M -104.5% 4.5% +17 pp €33.88M -130.2% 19.3% +11 pp
    €10.54M +29.6% -€176.44M +189.9% -1,673.8% -9.3 pp -€112.28M +220.1% -1,065.1% -6.3 pp
    €8.14M -54.1% -€60.87M +177.5% -748.1% -6.2 pp -€35.07M +630.7% -431.1% -4.0 pp
    €17.73M +32.0% -€21.94M +18.1% -123.7% +0.15 pp -€4.80M -70.8% -27.1% +0.95 pp
    €13.44M +21.2% -€18.58M +99.8% -138.3% -0.54 pp -€16.45M +9,125.8% -122.4% -1.2 pp
    €11.09M -36.2% -€9.30M -55.7% -83.9% +0.37 pp -€178.27K -98.9% -1.6% +0.92 pp
    €17.38M +232.1% -€20.99M +26.5% -120.7% +2.0 pp -€16.35M +6.7% -94.0% +2.0 pp
    €5.24M +∞% -€16.59M -40.8% -316.9% -3.2 pp -€15.32M -36.4% -292.7% -2.9 pp
    €0.00 +NaN% -€28.01M +211.3% N/A -€24.09M +286.2% N/A
    €0.00 +NaN% -€9.00M +568.0% N/A -€6.24M +361.5% N/A
    €0.00 +NaN% -€1.35M -59.8% N/A -€1.35M -32.2% N/A
    €0.00 -€3.35M N/A -€1.99M N/A

    Notifications